Acadia Pharmaceuticals (ACAD) Tax Rate (2017 - 2026)
Acadia Pharmaceuticals (ACAD) recorded quarterly Tax Rate of 7.5% in Q1 2026, up 100.8% quarter-over-quarter from 939.97% in Q4 2025, and down 2415.0% on a YoY basis from 0.32% in Q1 2025.
Acadia Pharmaceuticals (ACAD) Tax Rate (2017 - 2026) Analysis & Trends
Acadia Pharmaceuticals' Tax Rate history runs 10 years deep, the most recent figure standing at 7.5% for Q1 2026.
- In Q1 2026, Tax Rate fell 2415.0% year-over-year to 7.5%; the TTM figure through Mar 2026 stood at 226.4% (down 23998.0% YoY), while the FY2025 annual figure was 181.49%, down 19374.0% from the prior year.
- Tax Rate was 7.5% for Q1 2026 at Acadia Pharmaceuticals, up from 939.97% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 81.98% in Q2 2023 to a low of 939.97% in Q4 2025.
- Historically, Tax Rate has averaged 48.89% across 5 years, with a median of 4.27% in 2023.
- The sharpest annual moves came in 2023 and 2025: Tax Rate surged 8317 bps in 2023, then slumped 95072 bps in 2025.
- A 5-year view of Tax Rate shows it stood at 2.03% in 2022, then tumbled by 655 bps to 15.36% in 2023, then soared by 170 bps to 10.76% in 2024, then slumped by 8840 bps to 939.97% in 2025, then surged by 101 bps to 7.5% in 2026.
- The last three Tax Rate figures came in at 7.5% (Q1 2026), 939.97% (Q4 2025), and 60.96% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -57.14 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -6.79 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 5.61 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 17.68 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Acadia Pharmaceuticals | 3.68 Bn | 2.83 Bn | 243.27 Mn | 7.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.50% |
| Mar 31, 2026 | 7.50% |
| Dec 31, 2025 | -939.97% |
| Dec 31, 2025 | -939.97% |
| Sep 30, 2025 | -60.96% |
| Sep 30, 2025 | -60.96% |
| Jun 30, 2025 | 33.69% |
| Jun 30, 2025 | 33.69% |
| Mar 31, 2025 | 31.65% |
| Mar 31, 2025 | 31.65% |
| Dec 31, 2024 | 10.76% |
| Dec 31, 2024 | 10.76% |
| Sep 30, 2024 | 15.57% |
| Sep 30, 2024 | 15.57% |
| Jun 30, 2024 | 10.22% |
| Jun 30, 2024 | 10.22% |
| Mar 31, 2024 | 21.18% |
| Mar 31, 2024 | 21.18% |
| Dec 31, 2023 | -15.36% |
| Dec 31, 2023 | -15.36% |